The Colleen Giblin Research Laboratories for Child Neurology

Giblin Lecture

Please check back for the information on the upcoming Awardee and Colleen Giblin Lecture

List of Past Awardees and Lectures:

  • 1986: Darell D. Bigner, MD, PhD
    “What Does the Scientific Revolution in Molecular and Cellular Biology Mean to the Clinician Treating Patients with Brain Tumors”
  • 1987: Robert A. Weinberg, PhD
    “Oncogenes & Anti-Oncogenes”
  • 1988: Bengt Westermark, PhD
    “Growth Factors and Oncogenes in Human Malignant Glioma”
  • 1989: Webster K. Cavenee, PhD
    “Recessive Oncogenes in Human Tumor Predis-position and Progression”
  • 1990: J. Michael Bishop, MD
    “Oncogenes: Bench to Bedside”
  • 1991: Francis S. Collins, MD, PhD
    “Molecular Genetics of Neurofibromatosis”
  • 1992: Kay E. Davies, MA, DPhil
    “Molecular Analysis of the Fragile-X Syndrome”
  • 1993: Bert Vogelstein, MD
    “Genetic Basis of Human Cancer”
  • 1994: R. Michael Blaese, MD
    “Progress in Gene Therapy”
  • 1995: James F. Gusella, PhD
    “The Power of Merlin”
  • 1996: Yosef Shiloh, PhD
    “Molecular Genetics of Ataxia-Telangiectasia: Broader Implications for Cancer Research”
  • 1997: Huda Y. Zoghbi, MD
    “The Rise of Repeats and the Fall of Neurons: Implications for Pathogenesis”
  • 1998: Hugo W. Moser, MD
    “Genetics, Pathogenesis and Therapy of Adrenoleuko-dystrophy and Other Perioxisomal Disorders”
  • 1999: Judah Folkman, MD
    “Angiogenic Research: Experimental & Clinical Studies”
  • 2000: Christopher A. Walsh, MD, PhD
    “Scrambling, Doubling, and Disabling the Human Brain: Genes Required for Cerebral Cortical Development”
  • 2001: Joseph J. Volpe, MD
    “Brain Injury in the Premature Infant – From Pathogenesis to Prevention”
  • 2002: Elizabeth H. Blackburn, PhD
    “Telomerase, Cell Proliferation and Cell Death”
  • 2003: Gideon Dreyfuss, PhD
    “The Survival of Motor Neurons Complex: An Assembly Machine for Ribonucleoprotein Particles”
  • 2004: Scott L. Pomeroy, MD, PhD
    “Using Genomics to Identify Molecular Therapeutic Targets in Central Nervous System Embryonal Tumors”
  • 2005: Kevin P. Campbell, PhD
    “Molecular Pathogenesis of Muscular Dystrophy with Brain Malformations”
  • 2006: Tom Curran, PhD
    “Pediatric Brain Tumors: Promise & Problems Targeting the Sonic Hedgehog Pathway”
  • 2007: Michael Greenberg, PhD
    “Signaling Networks That Control Synapse Development and Human Cognitive Function”
  • 2008: Robert B. Darnell, MD, PhD
    “Brain Disease Aprés DNA: The Emerging Role of RNA”
  • 2009: Douglas C. Wallace, PhD
    “A Mitochondrial Paradigm for Metabolic and Degenerative Disease, Cancer and Aging: Why Do We Still have a Mitochondrial DNA?”
  • 2010: Thomas M. Jessell, PhD
    “The Ins and Outs of Spinal Motor Control”
  • 2011: Bradley L. Schlaggar, MD, PhD
    “Development of the Brain’s Functional Network Architecture”
  • 2012: Adrian Krainer, PhD
    “Targeted Modulation of Alternative Splicing as a Therapeutic Strategy”
  • 2013: Ingrid Tein, MD
    “Quenching Prometheus’ Fire: the Impact of Fatty Acid Oxidation Defects”
  • 2014: Francesco Muntoni, FRCPCH, FMedSci
    “On the Path to a Duchenne Muscular Dystrophy Therapy”
  •  2015: Joseph G. Gleeson, MD
    “Treating the Untreatable: Genetic Investigation of Pediatric Brain Disease”
  •  2016: Marcus E. Raichle, MD
    “The Restless Brain”
  •  2017: Mustafa Sahin, MD, PhD
    “Autism in Tuberous Sclerosis: From Circuits to Treatments”
  •  2018: Guangping Gao, PhD
    “Human Gene Therapy — The Road to Today and Beyond”
  •  2019: Joan Massagué, PhD
    “Regenerative Origin of Tumor Propagating Cells”